Scarica l'app Stockscreener
32.34
1.09%
0.275
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
IBM-Moderna Showcase Quantum-Enhanced Drug Discovery - HPCwire
Nisa Investment Advisors LLC Purchases 21,330 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine. - Barron's
Moderna’s latest approval again reveals FDA rift over COVID vaccines - BioPharma Dive
OVERSEA CHINESE BANKING Corp Ltd Raises Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
William Blair Issues Negative Outlook for Moderna Earnings - MarketBeat
Cwm LLC Acquires 28,831 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
FDA Fully Approves Moderna’s COVID-19 Vaccine for Some Young Children - Vaccine Advisor
Lobbying Update: $100,000 of MODERNA US INC. lobbying was just disclosed - Quiver Quantitative
Moderna gets full FDA approval for kids COVID-19 vaccine - MSN
Moderna patent for mRNA vaccine knocked back, for now - Lawyerly
Moderna: Ready For The Redemption Arc (NASDAQ:MRNA) - Seeking Alpha
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA) - Yahoo Finance
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash - Yahoo Finance
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash - The Motley Fool
Bank of New York Mellon Corp Has $54.38 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Why Moderna (MRNA) Stock Is Falling Today - Yahoo Finance
FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults - The Globe and Mail
Class Action Filed Against Moderna, Inc. (MRNA) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
What to Expect From Moderna's Next Quarterly Earnings Report - MSN
What To Expect From Moderna's Next Quarterly Earnings Report - Barchart.com
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Teacher Retirement System of Texas - MarketBeat
Financial Gravity Asset Management Inc. Invests $1.28 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Lobbying Update: $20,000 of MODERNA INC. lobbying was just disclosed - Quiver Quantitative
Trend Tracker for (MRNA) - news.stocktradersdaily.com
Top Large Cap Stock Gainers Last WeekModerna (NASDAQ:MRNA), Coinbase Global (NASDAQ:COIN), Delta Air Lines (NYSE:DAL) - Benzinga
Moderna, Inc. (NASDAQ:MRNA) Stock Holdings Raised by Moloney Securities Asset Management LLC - MarketBeat
Moderna (NasdaqGS:MRNA) Added to Russell Midcap Indexes - Yahoo Finance
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 - aberdeennews.com
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
FDA approves Moderna COVID-19 vaccine for high-risk children - TechTarget
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - FinancialContent
FDA approves Moderna's COVID vaccine for children as young as 6 months old - Scripps News
Moderna COVID shot gets FDA approval for kids 6 months to 11 years - USA Today
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients - Yahoo Finance
Moderna Wins Full Approval for COVID-19 Shot for Higher-Risk Kids - BioSpace
Moderna (NASDAQ:MRNA) Shares Up 8.4%Here's What Happened - MarketBeat
Moderna’s COVID vaccine gets full US approval for at-risk children aged 6 months and older - MSN
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease - Great Falls Tribune
FDA gives full approval to Moderna COVID shot for at-risk kids - The Hill
Moderna stock rises after FDA approves COVID-19 vaccine for at-risk children - Investing.com Nigeria
Pfizer Takes Aim At Moderna's Leftover MRNA Protections - Law360
Moderna COVID shot for kids cleared in face of RFK Jr. criticism - The Boston Globe
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months - Benzinga
FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility - STAT
Moderna gets full US approval for COVID shot in at-risk children 6 months and older - Reuters
Moderna COVID vaccine gets full approval for children - BioPharma Dive
Why Moderna (MRNA) Stock Is Up Today - TradingView
Moderna Stock Has Risen 19% This Month. Is It Now A Buy? - Investor's Business Daily
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older - Stocktwits
Moderna Wins US FDA Clearance for Updated COVID-19 Vaccine for At-risk Children - MarketScreener
Moderna’s Covid Shot Fully Approved by FDA for Use in Children - Bloomberg
Moderna: Spikevax approved for children at increased risk - MarketScreener
3.69%
2.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):